Overexpression of HSF2-beta Inhibits Hemin-induced Heat Shock Gene Expression and Erythroid Differentiation in K562 Cells*

(Received for publication, January 15, 1997, and in revised form, March 20, 1997)

Sirpa Leppä Dagger §, Lila Pirkkala Dagger , Helena Saarento Dagger , Kevin D. Sarge par and Lea Sistonen Dagger **

From the Dagger  Turku Centre for Biotechnology, University of Turku, Åbo Akademi University, P. O. Box 123, FIN-20521 Turku, Finland,  Department of Biology, Åbo Akademi University, BioCity, FIN-20520 Turku, Finland, and par  Department of Biochemistry, Chandler Medical Center, University of Kentucky, Lexington, Kentucky 40536-0084

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Acquisition of heat shock factor 2 (HSF2) DNA binding activity is accompanied by induced transcription of heat shock genes in hemin-treated K562 cells undergoing erythroid differentiation. Previous studies revealed that HSF2 consists of two alternatively spliced isoforms, HSF2-alpha and HSF2-beta , whose relative abundance is developmentally regulated and varies between different tissues. To investigate whether the molar ratio of HSF2-alpha and HSF2-beta isoforms is crucial for the activation of HSF2 and whether the HSF2 isoforms play functionally distinct roles during the hemin-mediated erythroid differentiation, we generated cell clones expressing different levels of HSF2-alpha and HSF2-beta . We show that in parental K562 cells, the HSF2-alpha isoform is predominantly expressed and HSF2 can be activated upon hemin treatment. In contrast, when HSF2-beta is expressed at levels exceeding those of endogenous HSF2-alpha , the hemin-induced DNA binding activity and transcription of heat shock genes are repressed, whereas overexpression of HSF2-alpha results in an enhanced hemin response. Furthermore, the hemin-induced accumulation of globin, known as a marker of erythroid differentiation, is decreased in cells overexpressing HSF2-beta . We suggest that HSF2-beta acts as a negative regulator of HSF2 activity during hemin-mediated erythroid differentiation of K562 cells.


INTRODUCTION

Heat shock factors (HSFs)1 function as transcriptional activators of the cellular stress response (1). To date, three mammalian HSF proteins, HSF1, HSF2, and HSF4, have been identified (2-5). HSFs have a common core structure consisting of the well conserved DNA binding and oligomerization domains. The DNA binding domain located in the amino-terminal part of the protein mediates binding to a highly conserved heat shock response element (HSE) found in multiple copies in the promoter of heat shock genes. The oligomerization domain adjacent to the DNA binding domain consists of the hydrophobic heptad repeats A/B (HR-A/B) (also termed the leucine zipper repeats 1-3). This domain is responsible for trimerization, which is essential for the high affinity binding of HSFs to the HSE. The carboxyl-terminal hydrophobic heptad repeat HR-C (leucine zipper repeat 4) is also well conserved and has been implicated in maintaining HSFs in the inactive non-DNA binding form (6, 7). External to DNA binding and oligomerization domains, however, the homology between HSF1 and HSF2 is limited (<40%).

A fundamental difference between HSF1 and HSF2 is that they respond to distinct signals. HSF1 is the functional homologue of the general HSF that is activated by diverse forms of stress, such as elevated temperatures, heavy metals, and amino acid analogs (8-12). Upon activation, HSF1 is rapidly converted from a monomer to a trimer, hyperphosphorylated, and translocated into the nucleus (6, 11-13). Unlike HSF1, HSF2 is not activated by acute stress but is constitutively active in mouse embryonal carcinoma cells, at the blastocyst stage during mouse embryogenesis, and during spermatogenesis (14-16). These findings suggest that HSF2 functions as a regulator of heat shock gene expression during development and differentiation. The functional significance of HSF2 DNA binding activity in these biological processes is, however, unclear. The inducible binding of HSF2 to the hsp70 promoter, which closely correlates with the transcriptional induction of the hsp70 gene during the hemin-mediated erythroid differentiation of K562 cells, provides a well studied example of HSF2 acting as a signal-responsive transcription factor (17, 18). Unlike HSF1, the non-DNA binding form of HSF2 is a dimer, but similar to HSF1, HSF2 trimerizes upon activation. Other significant differences between HSF1 and HSF2 are that HSF2 is activated by slower kinetics, is not constitutively or inducibly phosphorylated, recognizes HSEs slightly differently, and is a less potent activator of heat shock gene expression than HSF1 (12, 17, 19).

In most cell types, HSF2 is present in a latent non-DNA binding form. However, in cells in which HSF2 is constitutively active such as embryonal carcinoma cells, mouse blastocysts, and mouse testis, the expression levels of HSF2 are markedly elevated when compared with other cell types (14-16). Similarly, the acquisition of HSF2 DNA binding activity correlates with the increased levels of HSF2 in hemin-treated K562 cells (18). The existence of two distinct isoforms, HSF2-alpha and HSF2-beta , provides another level of regulation that adds further complexity to the function of HSF2 (20, 21). The smaller isoform, HSF2-beta , is generated from the nascent transcript by an additional splice, resulting in the deletion of an 18-amino acid sequence present in the larger HSF2-alpha isoform (21). The deletion is located adjacent to the HR-C and may cause modulation of the transcriptional activity of HSF2 since the HSF2-alpha isoform has been shown to be a more potent transcriptional activator than HSF2-beta in NIH 3T3 cells (21). Interestingly, the ratio of HSF2-alpha and HSF2-beta isoforms varies significantly between different mouse tissues such as brain, heart, and testis (21). In this study, we show that the hemin-mediated induction of hsp70 transcription is negatively regulated in K562 cells overexpressing HSF2-beta . Our results also suggest that the molar ratio of HSF2-alpha and HSF2-beta is likely to be of central relevance in the regulation of HSF2 activity. Finally, we propose that HSF2 activation is essential for the hemin-mediated erythroid differentiation of K562 cells.


EXPERIMENTAL PROCEDURES

Cell Culture and Transfections

Human K562 erythroleukemia cells were cultured in a humidified 5% CO2 atmosphere at 37 °C in RPMI 1640 supplemented with 10% fetal calf serum. Cells were heat-shocked at 42 °C or treated with 30 µM hemin as described earlier (22). To generate permanent cell clones overexpressing HSF2-alpha and HSF2-beta , 10 µg of the expression plasmids beta -actin-HSF2-alpha and beta -actin-HSF2-beta (12, 21) were transfected to K562 cells using electroporation. Host cells were washed twice with phosphate-buffered saline and electroporated (Gene PulserTM, Bio-Rad) in phosphate-buffered saline with 25 microfarad capacitance and 1.35 kV. Transfected cells were allowed to recover for 2 days, and neomycin-resistant cells were selected in medium containing G418 (500 µg/ml, Life Technologies, Inc.) for 2 weeks. Drug-resistant cells were diluted and selected for single cell clones for another 2 weeks. Cell clones that stably express HSF2-alpha and HSF2-beta were routinely maintained in medium containing G418 (500 µg/ml). Mock-transfected cells were used as a control. Before exposure to heat shock or hemin treatment, cells were plated in medium without G418.

SDS-PAGE and Western Blot Analysis

Whole cell extracts were prepared as described (10). Protein samples (10-20 µg) were separated on SDS-polyacrylamide gels (23) and transferred to a nitrocellulose filter using a semi-dry transfer apparatus (Bio-Rad). Western blotting was performed using immunoserum against mouse HSF1 and HSF2 as described (12). The inducible form of Hsp70 was detected by monoclonal antibody 4g4 (Affinity Bioreagents, Inc.). Hsp90 was detected by monoclonal antibody SPA-835 (StressGen Biotechnologies Corp.) and Hsc70 by monoclonal antibody SPA-815 (StressGen). Horseradish peroxidase-conjugated secondary antibodies were purchased from Promega and Amersham Life Science, Inc. The blots were developed with an enhanced chemiluminescence method (Amersham). Globin content was detected by Coomassie staining. Quantitation was performed using a computerized image analysis (Microcomputer Imaging Device version M4, Imaging Research Inc.).

Gel Mobility Shift Assay

A gel mobility shift analysis of protein·DNA complexes was performed as described previously (10). Briefly, whole cell extracts were incubated with a 32P-labeled oligonucleotide representing the proximal HSE of the human hsp70 promoter. Protein·DNA complexes were resolved on a 4% nondenaturing polyacrylamide gel.

Nuclear Run-on Analysis

Transcription run-on analysis was performed with equal numbers of isolated nuclei in the presence of 100 µCi of [alpha -32P]dUTP as described previously (24). Radiolabeled RNA was isolated and hybridized to nitrocellulose-immobilized plasmids specific for hsp70 (25), hsp90 (26), and beta -actin (27). Bluescript (Stratagene) was used as a vector control. The hybridization and washing conditions were as described (17). Quantitation was performed using phosphoimaging (Bio-Rad).

Northern Analysis

Total RNA was extracted from hemin-treated cells using a single-step method (28). 10 µg of RNA was separated on a 1% formaldehyde-agarose gel and transferred to a nylon membrane (Hybond-N, Amersham). The membranes were hybridized with [alpha -32P]dCTP-labeled probes specific for hsp70 (25) and beta -actin (27) according to the manufacturer's instructions.


RESULTS

Accumulation of HSF2 Is Increased in K562 Cells upon Hemin Treatment

To examine the molar ratio of the HSF2-alpha and HSF2-beta isoforms and the effect of hemin treatment on the expression of HSF2, K562 cells were exposed to hemin for various time periods and analyzed by Western blotting (Fig. 1A). In untreated cells, the levels of HSF2-alpha were approximately 2-fold higher as compared with those of HSF2-beta (Fig. 1C). Hemin treatment increased the abundance of both HSF2-alpha and HSF2-beta isoforms, and the increased amounts of HSF2 isoforms were observed within 6 h, in close correlation with the appearance of HSF2 DNA binding activity (Fig. 1B).


Fig. 1. Hemin increases the amount of HSF2 in K562 cells. A, levels of HSF2 protein in control (C), heat-shocked (HS), and hemin-treated (HE) cells. Equal amounts of protein (12 µg) were analyzed by SDS-PAGE and Western blotting using antibodies against HSF2 and HSF1. Subsequently, the blots were reprobed with antibodies against Hsp70 and Hsp90. B, HSE binding activity in control (0), heat-shocked (HS), and hemin-treated (HE) cells. Whole cell extracts were analyzed by gel mobility shift assay using a HSF-specific oligonucleotide probe. HSF indicates the specific inducible HSF-HSE complex, CHBA indicates the constitutive HSE binding activity that is not due to HSF1 or HSF2, and NS indicates nonspecific protein-DNA interaction. C, quantitation of HSF2-alpha and HSF2-beta isoforms. The HSF2-alpha and HSF2-beta bands shown in the inset were quantitated using computerized image analysis. The slower migrating band corresponds to HSF2-alpha and the faster migrating band to HSF2-beta .
[View Larger Version of this Image (51K GIF file)]

The amounts of HSF1 as well as Hsp70 and Hsp90 were analyzed in comparison with HSF2 in the same samples (Fig. 1A). Hemin treatment of K562 cells did not affect the accumulation of HSF1. The heat shock response was shown to be typical (Fig. 1A), as characterized by the retarded mobility on SDS-PAGE due to the inducibly phosphorylated state of HSF1 (12, 29) and the kinetics of DNA binding activation (Fig. 1B). Accumulation of Hsp70 protein in cells exposed to either heat shock or hemin treatment correlated well with previous results showing transcriptional induction of hsp70 upon heat shock and hemin treatments (Refs. 17 and 18; see also Fig. 3), whereas the levels of Hsp90 did not markedly change upon exposure to heat shock or hemin.


Fig. 3. Overexpression of HSF2-beta suppresses the hemin-mediated induction of heat shock gene expression. A, transcription rates of hsp70, hsp90, and beta -actin genes were analyzed by nuclear run-on assay. Equal numbers of nuclei from the control (C), heat shocked (HS) and hemin-treated (HE) K562 cells, mock-transfectants, and cells overexpressing HSF2 isoforms (see Table I for details of cell clones) were used to isolate labeled transcripts that were hybridized to the immobilized probes. Bluescript was used as a vector control. B, quantitative analysis of hsp70 and hsp90 transcription upon 16- and 24-h exposure to hemin as compared with basal transcription in untreated cells (value 1). beta -Actin was used as an internal control. C, steady-state levels of hsp70 and beta -actin mRNAs in untreated (C) and hemin-treated (HE) K562 cells. Transfectants were analyzed by Northern blotting. The mRNA sizes are indicated on the right. kb, kilobases.
[View Larger Version of this Image (36K GIF file)]

Altering the Molar Ratios of HSF2 Isoforms by Overexpression of HSF2-alpha and HSF2-beta in K562 Cells

The result showing that HSF2-alpha is predominantly expressed in K562 cells (Fig. 1C) raised the possibility that the relative abundance of HSF2 isoforms could be crucial for HSF2 activation and that HSF2-alpha and HSF2-beta might play functionally distinct roles in the hemin-mediated regulation of heat shock gene expression. For this purpose, we generated cell clones that stably express mouse HSF2-alpha and HSF2-beta under the control of the human beta -actin promoter (30). K562 cells were used as recipients for the expression plasmids (12, 21). More than 15 single cell clones for each transfection were isolated, and the expression of the distinct HSF2 isoforms was determined by Western blotting. Table I summarizes the characteristics of the cell clones that were chosen for further analysis. As the mouse HSF2 protein shows extensive homology with the human HSF2 (>95%), it is likely to function also in human cells. However, different mobilities of mouse and human HSF2 on SDS-PAGE (12) allowed us to estimate the relative expression levels of the exogenous HSF2 isoforms. Among several single cell clones transfected with beta -actin-HSF2-alpha , the 2alpha -F4 and 2alpha -C7 cells expressed the highest levels of HSF2-alpha and were chosen for further studies. Quantitation revealed that the ratio of total HSF2-alpha to HSF2-beta was increased 2-2.5-fold in 2alpha -F4 cells and 2alpha -C7 cells, respectively, as compared with the parental K562 cells and the mock-transfected cells (vector). The representative HSF2-beta clones (2beta -C8, 2beta -D5, 2beta -E7) expressed 3-5-fold higher levels of HSF2-beta than the control cells.

Table I. Characteristics of the transfected cell lines


Cell type Cell clone HSF2-alpha /HSF2-beta a Hemin responseb
Heat shock responseb
HSE binding hsp70 transcription HSE binding hsp70 transcription

Parental cells K562 2.1 + + ++ ++
Mock-transfected cells vector 2.0 + + ++ ++
HSF2-alpha -transfected cells 2alpha -C7 4.9 ++ ++ ++ ++
2alpha -F4 3.9 + + ++ ++
HSF2-beta -transfected cells 2beta -C8 0.6  -  - ++ ++
2beta -D5 0.4  -  - ++ ++
2beta -E7 0.5  -  - ++ ++

a The ratio of HSF2-alpha to HSF2-beta was quantitated from the Western blot using computerized image analysis.
b DNA binding activities and transcription of hsp70 were quantitated by phosphoimaging and scored as follows: -, no induction or only a weak induction; +, moderate induction; ++, strong induction.

To examine the effect of the exogenously expressed HSF2-alpha and HSF2-beta on the hemin-mediated increase in HSF2 levels, the transfectants were treated with hemin and analyzed by Western blotting (Fig. 2). Similar to the parental K562 cells (Fig. 1), hemin treatment resulted in increased accumulation of the HSF2 isoforms in mock-transfected cells (Fig. 2, vector). In 2alpha -C7 cells expressing exogenous HSF2-alpha , both endogenous and exogenous HSF2 levels were elevated. Surprisingly, the hemin-mediated increase in the endogenous HSF2 was repressed in HSF2-beta -overexpressing cells (2beta -D5). This repression was detected in all HSF2-beta cell clones. Analysis of HSF1 revealed that none of the mock-transfected cells or cells expressing exogenous HSF2 isoforms showed changes in accumulation or phosphorylation state of the endogenous HSF1 (data not shown).


Fig. 2. Overexpression of HSF2-beta represses the hemin-mediated increase in HSF2 and Hsp70 protein levels. Mock-transfected cells (vector) and K562 cells transfected with mouse HSF2-alpha (2alpha -C7) or HSF2-beta (2beta -D5) isoforms were exposed to hemin (HE) for 16 and 24 h. Equal amounts of protein (18 µg) were analyzed by Western blotting as described in Fig. 1. In the panel showing HSF2 protein levels, the upper double band corresponds to the endogenous HSF2 isoforms as indicated in Fig. 1. The exogenously expressed mouse HSF2-alpha and HSF2-beta are marked by arrows.
[View Larger Version of this Image (38K GIF file)]

We also analyzed the accumulation of Hsp70 and Hsc70 during hemin treatment of the transfected cell clones (Fig. 2). Interestingly, the accumulation of Hsp70 was markedly reduced in the hemin-treated cells overexpressing HSF2-beta as compared with the mock-transfected and HSF2-alpha -transfected cells. As expected, the levels of the constitutively expressed Hsc70 were not affected. Based on these results, we conclude that overexpression of HSF2-beta inhibits the increase in HSF2 amounts and consequently prevents the hemin-mediated accumulation of Hsp70.

Overexpression of HSF2-beta Represses the Hemin-induced Heat Shock Gene Transcription Due to Inhibition of HSF2 DNA Binding Activity

Since our results presented in Fig. 2 suggest that HSF2-beta functions as a repressor of the hemin-induced increase in Hsp70 accumulation, we wanted to determine at which molecular level the repression occurs. First, we analyzed whether the reduced accumulation of Hsp70 was caused by a corresponding decrease in hsp70 transcription. The production of hsp70 and hsp90 transcripts were measured by nuclear run-on assay using nuclei isolated from the parental K562 cells, the mock-transfected cells (vector), and the cells transfected with HSF2-alpha (2alpha -F4) and HSF2-beta (2beta -D5, 2beta -C8). The results presented in Fig. 3A and quantitated in Fig. 3B show that the repression of Hsp70 indeed occurs at the transcriptional level in the hemin-treated cells overexpressing HSF2-beta , as only a weak, if any, hemin-mediated induction of hsp70 transcription could be detected. Similarly, the hemin-mediated induction of hsp90 transcription was repressed due to overexpression of HSF2-beta . In contrast, all other cell clones showed the characteristic transcriptional induction of heat shock genes upon hemin treatment. The transcriptional repression of hsp70 and hsp90 genes in HSF2-beta -overexpressing cells was specific for hemin treatment since exposure to heat shock resulted in an equally prominent induction of heat shock gene transcription in all cells. The repression of hsp70 gene expression in HSF2-beta -overexpressing cells was observed also at the steady-state mRNA level as analyzed by Northern blotting (Fig. 3C).

HSF2-alpha and HSF2-beta have identical DNA binding and oligomerization domains. The only alteration in HSF2-beta is the deletion of an 18-amino acid sequence located immediately adjacent to the carboxyl-terminal HR-C (21). Thus, HSF2-beta would be expected to compete with HSF2-alpha for binding to HSE. To test this assumption, we next analyzed HSE binding activity in untreated and hemin-treated cells (Fig. 4). As expected, hemin treatment induced the HSE binding activity in parental K562 cells (Fig. 1B), mock-transfected cells (vector), and cells overexpressing HSF2-alpha (2alpha -C7, 2alpha -F4). Surprisingly, despite the presence of a DNA binding domain in the HSF2-beta isoform, the formation of a protein·HSE complex was prevented in the hemin-treated cells overexpressing HSF2-beta . This inhibition of DNA binding activity was detected in all HSF2-beta cell clones (2beta -D5, 2beta -C8, 2beta -E7). Quantitation revealed that overexpression of HSF2-alpha in 2alpha -C7 cells potentiated the binding to HSE. In accordance with the transcriptional induction of heat shock genes (Fig. 3A), DNA binding activity was strongly induced upon heat shock (Table I and data not shown), indicating that the HSF1-mediated heat shock response is not affected by overexpression of HSF2-beta .


Fig. 4. Inhibition of hemin-mediated DNA binding activity in cells overexpressing HSF2-beta . Whole cell extracts from untreated (C) and hemin-treated (HE) transfectants (see Table I for details of cell clones) were analyzed by gel mobility shift assay using an HSE-oligonucleotide probe. HSF, specific inducible HSF·HSE complex; CHBA, constitutive HSE binding activity; NS, nonspecific protein-DNA interaction.
[View Larger Version of this Image (65K GIF file)]

HSF2 Activation Is Involved in the Hemin-mediated Erythroid Differentiation of K562 Cells

Hemin-induced erythroid differentiation of K562 cells was confirmed by analyzing globin accumulation using Coomassie staining. In agreement with previous studies (31, 32), increased accumulation of globin was apparent after 3 days of exposure to hemin (Fig. 5). To elucidate whether HSF2 activity is involved in the hemin-induced erythroid differentiation, the globin content was determined in HSF2-alpha and HSF2-beta transfectants. As shown in Fig. 5, overexpression of HSF2-beta decreased the hemin-induced globin accumulation by 40-60% (2beta -D5, 2beta -E7), whereas globin induction was potentiated in HSF2-alpha -overexpressing cells (2alpha -F4, 2alpha -C7). Taken together, our results indicate that the HSF2-beta isoform functions as a negative regulator of heat shock gene expression and that HSF2 activity is essential for the hemin-induced erythroid differentiation of K562 cells.


Fig. 5. Accumulation of globin in differentiating K562 cells is decreased by overexpression of HSF2-beta . Soluble proteins (15 µg) from untreated (C) and hemin-treated (HE, 72 h) K562 cells and cells overexpressing HSF2-alpha and HSF2-beta were separated on a 15% SDS-PAGE and stained with Coomassie Blue. Quantitation of globin (filled arrow) was performed by computerized image analysis. Globin signals were corrected for an internal control (open arrow), and the induced accumulation of globin in transfectants was compared with that in K562 cells (100%). The relative values of globin accumulation are listed below the gel image.
[View Larger Version of this Image (100K GIF file)]


DISCUSSION

Signal-dependent regulation of transcription factors plays a critical role in the processes underlying cellular differentiation and development. HSF2 has been shown to be active during mouse embryogenesis at blastocyst stage, during mouse spermatogenesis, during hemin-induced erythroid differentiation of K562 cells, and in mouse embryonal carcinoma cells (14-17). Characteristic of the cells involved in these processes is abundant expression of HSF2 as compared with other cell types. Furthermore, HSF2-alpha is the predominantly expressed isoform in spermatogenic cell types in testis (21). Based on these results, it has been suggested that increased expression of HSF2 as well as the relative abundance of the HSF2 isoforms might contribute to HSF2 activation. Our results provide evidence that besides increased expression of HSF2, a molar excess of HSF2-alpha is required for HSF2 activation in K562 cells. Our results further suggest that HSF2-alpha and HSF2-beta have distinct functions during hemin-mediated erythroid differentiation, as HSF2-alpha acts as a potential activator and HSF2-beta as a suppressor of the hemin-induced transcription of heat shock genes in K562 cells.

Using cell lines that express altered molar ratios of HSF2-alpha and HSF2-beta , we examined the regulation and the functional significance of the alternatively spliced HSF2 isoforms during the hemin-mediated erythroid differentiation. We observed that excess of HSF2-beta prevents the hemin-mediated HSE binding activity and subsequent induction of heat shock gene transcription. Furthermore, overexpression of HSF2-beta specifically inhibits the hemin-mediated increase in the levels of both endogenous and exogenous HSF2. These results raise the interesting possibility that HSF2-beta negatively controls the amount of HSF2 protein accumulated in a cell. This type of regulation could be a relevant mechanism to attenuate the hemin-mediated induction of heat shock gene expression. Our results further suggest that HSF2-alpha could counteract the inhibitory effect of HSF2-beta on HSF2 DNA binding and transcriptional activity only when the molar ratio of HSF2-alpha to HSF2-beta is favorable, i.e. HSF2-alpha is predominantly expressed. However, overexpression of HSF2-alpha alone is not sufficient to activate HSF2 in K562 cells, but another factor, such as hemin, is required for activation.

Yet, it is not clear whether hemin mediates the action on HSF2 directly by binding to the molecule or by triggering some post-translational modifications thereby resulting in conformational change in HSF2. Interestingly, as hemin-mediated activation of HSF2 is accompanied by an increase in the levels of both HSF2 isoforms, the conformations of HSF2-alpha and HSF2-beta might be differentially affected by hemin. An example of a hemin-regulated transcription factor is HAP1, which in yeast activates transcription of genes encoding cytochromes in response to oxygen and hemin (33, 34). HSF2, however, does not contain a sequence similar to the HAP1 repeat, termed hemin regulatory motif, that binds hemin directly (35). Furthermore, the kinetics of HSF2 activation upon hemin treatment is relatively slow, varying between 6 and 16 h of hemin exposure (Ref. 17 and this study). Based on these results and the fact that hemin is known to be an important regulator of protein synthesis (36), it is tempting to speculate that the hemin-induced increase in HSF2 levels and acquisition of HSF2 DNA binding activity could be consequences of changes in protein synthesis leading to a requirement for elevated levels of molecular chaperones.

There are multiple examples where changes in RNA splicing result in transcription factor isoforms with altered activities. For example, certain AP-2 isoforms function as inhibitors of transactivation due to a deletion in the oligomerization domain, which is necessary for DNA binding (37). Splicing can also result in deletion of sequences required for full transactivation potential as exemplified by the Fos-related proteins (38-40). Analyses of different family members of nuclear steroid hormone receptors, c-ErbA and RORalpha , have revealed that their distinct DNA binding properties are dictated by the specific amino-terminal domains (41, 42). In the case of HSF2-beta , alternative splicing eliminates 18 amino acids adjacent to the HR-C, and HR-C has been implicated in maintaining HSFs in the inactive, non-DNA binding form (6, 7). According to Goodson et al. (21), the deletion in HSF2-beta resulted in poor transactivation capacity in transiently transfected NIH 3T3 cells without affecting the DNA binding activity. However, our results showing that overexpression of HSF2-beta in K562 cells interferes with HSF2 DNA binding lead us to conclude that the hemin-induced HSF2 DNA binding activity is controlled by this specific sequence adjacent to the HR-C located in the carboxyl-terminal region of the protein. We propose that the different results obtained earlier and in this study are likely to be due to experimental differences reflecting specific features of the different cell types and distinct expression levels of HSF2-beta . Interestingly, HSF4, a novel human HSF lacking the properties of a transcriptional activator, has recently been identified (5). In HeLa cells, which do not express endogenous HSF4, overexpression of HSF4 was shown to lead to constitutive HSE binding activity and repression of target genes, which could be related to the fact that HSF4 lacks the HR-C. Thus, despite the similar effects of overexpression of HSF4 and HSF2-beta on gene expression, these factors seem to be functionally distinct, and the mechanism(s) by which overexpression of HSF2-beta prevents HSF2 DNA binding activity remains to be established.

The biologically relevant finding that HSF2 activity is essential for the regulation of hemin-induced erythroid differentiation of K562 cells is based on our results showing that globin accumulation upon hemin treatment is differentially affected by overexpression of HSF2 isoforms. The enhancing and inhibiting effects of HSF2-alpha and HSF2-beta , respectively, on the signaling cascades leading to activation of HSF2 and subsequently to accumulation of Hsp70 and globin suggest that HSF2 plays a critical role during progression of cells to erythroid differentiation. We also demonstrate that the HSF1-mediated heat shock response is not affected by overexpression of HSF2-beta and thus provides support for earlier studies implying that hemin-induced accumulation of Hsp70 in the differentiated erythroblasts of both K562 and bone marrow reflects a differentiation event rather than a general response to stress conditions (43). Future studies will be directed toward elucidating whether activation of HSF2 functions as a trigger in the initiation phase of erythroid differentiation and determining by which mechanisms HSF2 activity is regulated in cells undergoing differentiation.


FOOTNOTES

*   This work was supported by the Academy of Finland, the Emil Aaltonen Foundation, the Finnish Cultural Foundation, the Finnish Cancer Foundation, and the Sigrid Jusélius Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Present address: European Molecular Biology Laboratory, P. O. Box 10.2209, D-69012 Heidelberg, Germany.
**   To whom correspondence should be addressed. Tel.: 358-2-333 8028; Fax: 358-2-333 8000; E-mail: lea.sistonen{at}btk.utu.fi.
1   The abbreviations used are: HSF, heat shock factor; HSE, heat shock element; Hsp, heat shock protein; Hsc, heat shock protein cognate; HR, heptad repeat; PAGE, polyacrylamide gel electrophoresis.

ACKNOWLEDGEMENTS

We thank Minna Lönnström for expert technical assistance and Fiorenzo Peverali for valuable advice on photography. Dirk Bohmann, John E. Eriksson, and Päivi J. Koskinen are acknowledged for discussions and critical review of the manuscript.


REFERENCES

  1. Wu, C. (1995) Annu. Rev. Cell Dev. Biol. 11, 441-469 [CrossRef][Medline] [Order article via Infotrieve]
  2. Rabindran, S. K., Giorgi, G., Clos, J., and Wu, C. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6906-6910 [Abstract]
  3. Sarge, K. D., Zimarino, V., Holm, K., Wu, C., and Morimoto, R. I. (1991) Genes Dev. 5, 1902-1911 [Abstract]
  4. Schuetz, T. J., Gallo, G. J., Sheldon, L., Tempst, P., and Kingston, R. E. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6911-6915 [Abstract]
  5. Nakai, A., Tanabe, M., Kawazoe, Y., Inazawa, J., Morimoto, R. I., and Nagata, K. (1997) Mol. Cell. Biol. 17, 469-481 [Abstract]
  6. Rabindran, S. K., Haroun, R. I., Clos, J., Wisniewski, J., and Wu, C. (1993) Science 259, 230-234 [Medline] [Order article via Infotrieve]
  7. Zuo, J., Baler, R., Dahl, G., and Voellmy, R. (1994) Mol. Cell. Biol. 14, 7557-7568 [Abstract]
  8. Sorger, P. K., Lewis, M. J., and Pelham, H. R. B. (1987) Nature 329, 81-84 [CrossRef][Medline] [Order article via Infotrieve]
  9. Amin, J., Ananthan, J., and Voellmy, R. (1988) Mol. Cell. Biol. 8, 3761-3769 [Medline] [Order article via Infotrieve]
  10. Mosser, D. D., Theodorakis, N. G., and Morimoto, R. I. (1988) Mol. Cell. Biol. 8, 4736-4744 [Medline] [Order article via Infotrieve]
  11. Baler, R., Dahl, G., and Voellmy, R. (1993) Mol. Cell. Biol. 13, 2486-2496 [Abstract]
  12. Sarge, K. D., Murphy, S. P., and Morimoto, R. I. (1993) Mol. Cell. Biol. 13, 1392-1407 [Abstract]
  13. Westwood, J. T., Clos, J., and Wu, C. (1991) Nature 353, 822-827 [CrossRef][Medline] [Order article via Infotrieve]
  14. Mezger, V., Rallu, M., Morimoto, R. I., Morange, M., and Renard, J-P. (1994) Dev. Biol. 166, 819-822 [CrossRef][Medline] [Order article via Infotrieve]
  15. Murphy, S. P., Gorzowski, J. J., Sarge, K. D., and Phillips, B. (1994) Mol. Cell. Biol. 14, 5309-5317 [Abstract]
  16. Sarge, K. D., Park-Sarge, O.-K., Kirby, J. D., Mayo, K. E., and Morimoto, R. I. (1994) Biol. Reprod. 50, 1334-1343 [Abstract]
  17. Sistonen, L., Sarge, K. D., Phillips, B., Abravaya, K., and Morimoto, R. I. (1992) Mol. Cell. Biol. 12, 4104-4111 [Abstract]
  18. Sistonen, L., Sarge, K. D., and Morimoto, R. I. (1994) Mol. Cell. Biol. 14, 2087-2099 [Abstract]
  19. Kroeger, P. E., Sarge, K. D., and Morimoto, R. I. (1993) Mol. Cell. Biol. 13, 3370-3383 [Abstract]
  20. Fiorenza, M. T., Farkas, T., Dissing, M., Kolding, D., and Zimarino, V. (1995) Nucleic Acids Res. 23, 467-474 [Abstract]
  21. Goodson, M. L., Park-Sarge, O.-K., and Sarge, K. D. (1995) Mol. Cell. Biol. 15, 5288-5293 [Abstract]
  22. Theodorakis, N. G., Zand, D. J., Kotzbauer, P. T., Williams, G. T., and Morimoto, R. I. (1989) Mol. Cell. Biol. 9, 3166-3173 [Medline] [Order article via Infotrieve]
  23. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  24. Banerji, S. S., Theodorakis, N. G., and Morimoto, R. I. (1984) Mol. Cell. Biol. 4, 2437-2448 [Medline] [Order article via Infotrieve]
  25. Wu, B., Hunt, C., and Morimoto, R. I. (1985) Mol. Cell. Biol. 5, 330-341 [Medline] [Order article via Infotrieve]
  26. Hickey, E., Brandon, S. E., Smale, G., Lloyd, D., and Weber, L. A. (1989) Mol. Cell. Biol. 9, 2615-2626 [Medline] [Order article via Infotrieve]
  27. Gunning, P., Ponte, P., Okayama, H., Engel, J., Blau, H., and Kedes, L. (1983) Mol. Cell. Biol. 3, 787-795 [Medline] [Order article via Infotrieve]
  28. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-157 [CrossRef][Medline] [Order article via Infotrieve]
  29. Cotto, J. J., Kline, M., and Morimoto, R. I. (1996) J. Biol. Chem. 271, 3355-3358 [Abstract/Free Full Text]
  30. Gunning, P., Leavitt, J., Muscat, G., Ng, S. Y., and Kedes, L. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 4831-4835 [Abstract]
  31. Dean, A., Erard, F., Schneider, A. B., and Schechter, A. N. (1981) Science 212, 459-461 [Medline] [Order article via Infotrieve]
  32. Haldeman, M. T., Finley, D., and Pickart, C. M. (1995) J. Biol. Chem. 270, 9507-9516 [Abstract/Free Full Text]
  33. Fytlovich, S., Gervais, M., Agrimonti, C., and Guiard, B. (1993) EMBO J. 12, 1209-1218 [Abstract]
  34. Zhang, L., and Guarante, L. (1994) J. Biol. Chem. 269, 14643-14647 [Abstract/Free Full Text]
  35. Zhang, L., and Guarante, L. (1995) EMBO J. 14, 313-320 [Abstract]
  36. Padmanaban, G., Venkateswar, V., and Rangarajan, P. N. (1989) Trends Biochem. Sci. 14, 492-496 [CrossRef][Medline] [Order article via Infotrieve]
  37. Buettner, R., Kannan, P., Imhof, A., Bauer, R., Yim, S. O., Glockshuber, R., Van Dyke, M. W., and Tainsky, M. A. (1993) Mol. Cell. Biol. 13, 4174-4185 [Abstract]
  38. Mumberg, D., Lucibello, F. C., Schuermann, M., and Müller, R. (1991) Genes Dev. 5, 1212-1223 [Abstract]
  39. Nakabeppu, Y., and Nathans, D. (1991) Cell 64, 751-759 [Medline] [Order article via Infotrieve]
  40. Yen, J., Wilson, R. M., Tratner, I., and Verma, I. M. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 5077-5081 [Abstract]
  41. Chen, H., Smit-McBride, Z., Lewis, S., Sharif, M., and Privalsky, M. L. (1993) Mol. Cell. Biol. 13, 2366-2376 [Abstract]
  42. Giguère, V., Tini, M., Flock, G., Ong, E., Evans, R. M., and Otulakowski, G. (1994) Genes Dev. 8, 538-553 [Abstract]
  43. Singh, M. K., and Yu, J. (1984) Nature 309, 631-633 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.